APG Asset Management’s Corcept Therapeutics CORT Stock Holding History

APG Asset Management’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,000	Closed	-$323K	–	722
2023 Q4	$323K	Sell	11,000 -11,900	-52%	-$327K	﹤0.01%	682
2023 Q3	$624K	Buy	+22,900	New	+$663K	﹤0.01%	615
2023 Q1	–	Sell	-61,000	Closed	-$1.24M	–	760
2022 Q4	$1.24M	Buy	61,000 +4,700	+8%	+$118K	﹤0.01%	679
2022 Q3	$1.47M	Buy	+56,300	New	+$1.51M	﹤0.01%	590
2021 Q4	–	Sell	-41,219	Closed	-$700K	–	935
2021 Q3	$700K	Sell	41,219 -104,800	-72%	-$2.19M	﹤0.01%	824
2021 Q2	$2.71M	Sell	146,019 -46,000	-24%	-$1.02M	﹤0.01%	615
2021 Q1	$3.89M	Hold	192,019	–	–	0.01%	598
2020 Q4	$4.11M	Buy	192,019 +67,000	+54%	+$1.41M	0.01%	675
2020 Q3	$1.86M	Buy	125,019 +94,000	+303%	+$1.5M	﹤0.01%	793
2020 Q2	$465K	Buy	+31,019	New	+$436K	﹤0.01%	881

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

APG Asset Management's CORT Position: Q1 2024 in Review

APG Asset Management sold out of Corcept Therapeutics (CORT) in Q1 2024, closing a stake of 11,000 shares — an estimated $323K sold.

APG Asset Management first reported a position in CORT in Q2 2020 and held it in 10 quarters. The position peaked at $4.11M in Q4 2020. 287 funds tracked by Wall St. Rank hold CORT as of Q1 2024.

APG Asset Management reported no remaining Corcept Therapeutics position as of Q1 2024 after selling out during the quarter.
APG Asset Management sold 11,000 Corcept Therapeutics shares in Q1 2024, an estimated $323K.
APG Asset Management first reported a position in Corcept Therapeutics in Q2 2020 and held it in 10 quarters.
APG Asset Management's Corcept Therapeutics position peaked at $4.11M in Q4 2020.
287 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2024.

Based on APG Asset Management's 13F filing for Q1 2024, filed 14 May 2024.